The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
What Level of Hepatitis B Antibody Is Protective?
Abstract
This study assessed the level of vaccine-induced hepatitis B surface antibody that is protective against hepatitis B infection and carriage in The Gambia. Sera from 700 of a cohort of 1041 children vaccinated against hepatitis B in infancy were serially tested for markers of hepatitis B until age 7 years. No absolute level of protection against infection was found, but all children who attained a peak antibody response to vaccination of >=10 IU/L were protected against carriage of hepatitis B surface antigen. Two-thirds of 45 infected children experienced brief infection (determined by loss of core antibody). This transient infection was likely related to surface antibody level. The data support the use of the peak antibody response as the best indicator of protection against carriage and suggest that most infections after vaccination are short-lived.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A novel hepatitis B virus variant in the sera of immunized children
Karthigesu, V. D., Allison, L. M. C., Fortuin, M., Mendy, M. E., Whittle, H., & Howard, C. R. (1994) · Journal of General Virology · doi:10.1099/0022-1317-75-2-443 · Cited by 128
Self-citationRandom-Effects Models for Longitudinal Data Using Gibbs Sampling
Gilks, W. R., Wang, C. C., Yvonnet, B., & Coursaget, P. (1993) · Biometrics · doi:10.2307/2532557 · Cited by 110
Fortuin, M., Karthigesu, V. D., Allison, L. H., Howard, C. R., Hoare, S., Mendy, M. E., & Whittle, H. (1994) · The Journal of Infectious Diseases · doi:10.1093/infdis/169.6.1374 · Cited by 90
Self-citation
Cited by
Correlates of protection induced by vaccination
Plotkin, S. A. (2010) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00131-10 · Cited by 1,745
Immunological mechanisms of vaccination
Pulendran, B., & Ahmed, R. (2011) · Nature Immunology · doi:10.1038/ni.2039 · Cited by 1,089
Vaccines: Correlates of Vaccine‐Induced Immunity
Plotkin, S. A. (2008) · Clinical Infectious Diseases · doi:10.1086/589862 · Cited by 829
Schillie, S., Vellozzi, C., Reingold, A., Harris, A., Haber, P., Ward, J. W., & Nelson, N. P. (2018) · MMWR. Recommendations and Reports · doi:10.15585/mmwr.rr6701a1 · Cited by 815
“Immunocompetent children and adults who have vaccine-induced anti-HBs levels of ≥10 mIU/mL 1–2 months after having received a complete HepB vaccine series are considered seroprotected and deemed vaccine responders (107).”
Background(2005) · PsycEXTRA Dataset · doi:10.1037/e548682006-001 · Cited by 753
Shouval, D. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(03)00152-1 · Cited by 470
EASL Clinical Practice Guidelines on the management of hepatitis B virus infection
Cornberg, M., Sandmann, L., Jaroszewicz, J., Kennedy, P., Lampertico, P., Lemoine, M., Lens, S., Testoni, B., Lai-Hung Wong, G., & Russo, F. P. (2025) · Journal of Hepatology · doi:10.1016/j.jhep.2025.03.018 · Cited by 437
Pulendran, B., Li, S., & Nakaya, H. I. (2010) · Immunity · doi:10.1016/j.immuni.2010.10.006 · Cited by 380
Hepatitis B and the Need for a Booster Dose
Leuridan, E., & Van Damme, P. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir270 · Cited by 308
Pattyn, J., Hendrickx, G., Vorsters, A., & Van Damme, P. (2021) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa668 · Cited by 282
Contributions of humoral and cellular immunity to vaccine-induced protection in humans
Amanna, I. J., & Slifka, M. K. (2011) · Virology · doi:10.1016/j.virol.2010.12.016 · Cited by 263
Keating, G. M., & Noble, S. (2003) · Drugs · doi:10.2165/00003495-200363100-00006 · Cited by 261
Gall, S. A., Myers, J., & Pichichero, M. (2011) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2010.11.024 · Cited by 226
Epidemiology and prevention of hepatitis B virus infection
Kwon, S. Y., & Lee, C. H. (2011) · The Korean Journal of Hepatology · doi:10.3350/kjhep.2011.17.2.87 · Cited by 171
Rondaan, C., Furer, V., Heijstek, M. W., Agmon-Levin, N., Bijl, M., Breedveld, F. C., D’Amelio, R., Dougados, M., Kapetanovic, M. C., van Laar, J. M., et al. (2019) · RMD Open · doi:10.1136/rmdopen-2019-001035 · Cited by 154
Seroprotection after recombinant hepatitis B vaccination among newborn infants: A review
Schillie, S. F., & Murphy, T. V. (2013) · Vaccine · doi:10.1016/j.vaccine.2012.12.012 · Cited by 105
Van Der Meeren, O., Peterson, J. T., Dionne, M., Beasley, R., Ebeling, P. R., Ferguson, M., Nissen, M. D., Rheault, P., Simpson, R. W., De Ridder, M., et al. (2016) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2016.1164362 · Cited by 34
Metadata
- Authors
- Jack, A. D., Hall, A. J., Maine, N., Mendy, M., & Whittle, H. C.
- Venue
- The Journal of Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 1999-02
- Volume
- 179
- Issue
- 2
- Pages
- 489-492
- ISSN
- 0022-1899 (ISSN-L)
- 1537-6613
- OpenAlex
- W2169380745
- Cited by
- 354
- References
- 3
- FWCI
- 4.08
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.